The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 123:1453-1455, May 1967
doi: 10.1176/appi.ajp.123.11.1453
© 1967 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by DOLENZ, B. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by DOLENZ, B. J.

Flurothyl (Indoklon) Side Effects

BERNARD J. DOLENZ M.D.1

1 Director and Chief-of-Staff, Fort Worth Neuropsychiatric Center and Hospital, 1066 W. Magnolia, Fort Worth, Tex. 76104

The technical difficulties and obviation factors of flurothyl treatment (ICT) are discussed. Toxic delirium problems, as well as a cardiac arrest patient who recovered, are described. It is felt that flurothyl is a new somatic treatment tool in psychiatry and that its effects are different from electrically-induced convulsions.

Contrary to what is generally thought about convulsive therapy, it is felt that there is a qualitative difference between the convulsions produced by ICT and by ECT. Patients who have not responded well to ECT have responded to ICT, and the converse is true. That the effects of flurothyl are more diffuse in the brain, that cerebrospinal fluid pressures are increased more, and that MAOs apparently influence the flurothyl-treated patients with blood pressure elevation suggest appreciable differences in the resultant convulsions and perhaps explain therapeutic response.







Get information about faster international access.

Privacy Policy

Copyright © 1967 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org